missing translation for 'onlineSavingsMsg'
Learn More
Learn More
MAPK3 (ERK1) Recombinant Human Protein
MAPK3 (ERK1) Recombinant Human Protein
Marca: Invitrogen PV3311
Detalles adicionales : Peso : 3.36000kg
Descripción
MAPK3 (ERK1) is a serine⁄threonine kinase that is an important activator of p90, RSK, MSK, ELK1, and Stat3, and is involved in the MAPK pathway.Especificaciones
| NP_002737 | |
| Cell Viability, Pharma and Biopharma, Cell Proliferation and Function, Protein Assays and Analysis, Target and Lead Identification and Validation, Kinase Assay | |
| 70.8kDa | |
| 10μg | |
| For research use only. Not for use in diagnostic procedures | |
| MAPK3 (ERK1) | |
| MAPK3 (ERK1) was pre-diluted in enzyme dilution buffer and assayed in 50mM Tris (pH 7.5), 10mM MgCl2, 1mM EGTA, 2mM DTT, 0.01% Triton™ X-100, 200μM ATP, 667μg/mL myelin basic protein (MBP) and trace [32P]-γ-ATP for 10 minutes at 30°C | |
| MAPK3 (ERK1) Recombinant Human Protein | |
| Human | |
| E. coli | |
| Serine/threonine kinase |
| 0.44mg/mL | |
| 5595 | |
| MAPK3 (ERK1) Recombinant Human Protein | |
| –80°C | |
| 1 Each | |
| MAPK3 (ERK1) Recombinant Human Protein | |
| MAP | |
| 140nmoles of phosphate transferred to myelin basic protein (MBP) per minute per mg of total protein at 30°C. Activity determined at a final protein concentration of 0.83μg/mL | |
| GST Tag | |
| Kinase and inhibitors | |
| 85% by SDS-PAGE |
For Research Use Only. Not for use in diagnostic procedures.